8/6/18. Patient Experience. effective management of Chronic Migraine and Occipital Neuralgia in the Post 9/11 Combat Veteran
|
|
- Vivien Young
- 5 years ago
- Views:
Transcription
1 8//8 Patient Experience Validation of practice based evidence for effective management of Chronic Migraine and Occipital Neuralgia in the Post 9/ Combat Veteran Karen Williams,MSN, RN, FNP-BC Neurology/Headache Clinic Central Texas Veterans Health Care System yo male with a history of refractory headaches increased after 00 deployment Started in 99 with parachute jump, hard landing, hit head to the left, with Loss of Consciousness (LOC)- 00- Improvised explosive Device (IED) blast with LOC Described as Left hemi-cranial throbbing/aching associated with photophobia/phonophobia, Nausea/Vomiting & worse with exertion. Rated as / Occurring - times per month lasting 3- days ~ (up to days per month debilitating headache, plus a daily posterior headache) Overview of the Headache Population Conceptual Framework The Headache clinic was established in November 03 Patient population: Refractory headache patients- most have failed Primary Care treatments, many have also failed Neurology, all seeking alternatives Common types of headache- Migraine, Occipital Neuralgia, Tension, Cervical degeneration Common co-occurring diagnosis- prior hx of head and/or neck injury, PTSD, Insomnia, Anxiety/Depression, Musculoskeletal pain, The Headache Clinic utilizes a Chronic Care Model Incorporate multiple modalities: Traditional and Alternative Medication Botox Occipital blocks Acupuncture Cefaly/Alpha-stim Relaxation techniques Aromatherapy (Peppermint oil) Patient education (continual) Study Purpose Headache clinic utilizes: o Onabotulinum A (BOTOX) every weeks o Occipital blocks every -8 weeks as needed o Treating combat veteran with a history of: traumatic brain injury(tbi) neck trauma/whiplash with chronic migraine (CM) occipital neuralgia o Based on the available evidence /anecdotally this seemed to be very effective o Validation through empirical practice based evidence was needed
2 8//8 Study Disclaimer This study: Was been reviewed and approved by the Central Texas Veterans Health Care System (CTVHCS) Institutional Review Board and University of Alabama at Tuscaloosa This material is the result of work supported by resources at the Central Texas Veterans Health Care System Does not necessarily express the views of the Department of Veterans Affairs or the United States Government nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government Background CM in the post 9/ combat veteran with a history of TBI- is 0% or more: even after years of treatment (Couch & Stewart 0; Patil et al., 0) General population CM rate is - % (Munakata et al., 009) CM causes: reduced work and quality of life, increase in ER and primary visits (Munakata et al., 009) Young population: average age of post 9/ combat with CM 9-30 years of age (Altalib et al., 0) Knowledge Gap Current treatments- medications for prevention (Topiramate) and Onabotulinum Toxin A (BOTOX)(Yerry, Kuehn, & Finkel, 0) Treatments failure- wear off of Botox before weeks and do not fully address the occipital neuralgia Occipital neuralgia is common after traumatic brain injury (TBI)/neck trauma and may be part of the CM (Ducic, Sinkin, & Crutchfield, 0; Zaremski, Herman, Clugston, Hurley, & Ahn, 0) Occipital Blocks have been an effective treatment for occipital neuralgia and short term relief of CM (Cuadrado et.al, 0; Gul, Ozon, Karadas, Koc, &; Inan, 0) (Onabotulinumtoxin A Botox ) Injection Paradigm 3 injections into 7 muscle groups Blumenfeld et. al, Headache 0;0:0-8. Cutaneous innervation of the head and neck The sensory distribution of the trigeminal nerve (cranial nerve V) and its three divisions (V, V, V3) are show along with branches of the cervical spinal nerves that innervate cutaneous regions of the head and neck. Occipital Nerve Anatomy Image courtesy of UpToDate
3 8//8 Occipital Block Injection Sites Methodology GON aiming slightly up maintaining a subcutaneous course LOC aiming lateral and up, maintaining a subcutaneous course Occipital block consisted of to ratio of % Lidocaine & 0.% Bupivacaine, ml into the greater and 0. ml into the lesser 3 Retrospective review of post 9/ combat veterans seen in the headache clinic between Jan, 0- Dec 3, 0 History of TBI or neck trauma/whiplash Findings of CM & Occipital Neuralgia Treated with Botox and Occipital Blocks 8 patient charts reviewed > 37 Dx w/cm & Occipital neuralgia > 7 excluded (did not fit all the criteria) > 30 were included Data Collection Number of self-reported headache days per month (8 days) o The month prior to treatment in the headache clinic o months after treatment in the headache clinic o Mean and 9% confidence interval for # of Headache days/month for pre and post intervention for each subject was computed o Binomial mixed regression model- to determine if the mean # of headache days is significantly lower post intervention Dependent Variables: headache days per month (8 days) Independent variables: age, gender, head or neck trauma, headache types (migraine, tension, occipital neuralgia, medication overuse), comorbid diseases (mood disorders of anxiety, depression or PTSD, musculoskeletal pain, insomnia), prior headache treatments and treatments in the headache clinic of Botox and occipital blocks 0% % 7% Number of Veterans in each age range 8 3% Veteran ages ranged 0 from 7 to. years of age. [7, 3.] (3.,.] (., 8.3] 80% were between the ages of 7 and. years Patient age PRIOR PREVENTATIVE MEDICATION TREATMENTS Topiramate Divalproex TCA Inderal Verapamil Gabapentin Number of Veterans Year of Headache Onset Headaches started after the head or neck trauma 9 Number in the graphic represents the number of veterans who had taken the medication for migraine prevention prior to treatment in the headache clinic. 3 veterans had trials of 3 or more medications
4 8//8 Gender Distribution of Patients Treated 30 Comorbid Conditions 0 Veteran 0 # of Males # of Females Some patients were diagnosed with PTSD & Anxiety or Depression PTSD = Post-traumatic Stress Disorder MSK = Musculoskeletal Disorder 0 PTSD Anxiety Depression MSK Insomnia Medical Diagnosis Results 30 Pre-Post Headache Frequency Mean number of headache days in the month prior to treatment was. (.0,.7)* Mean number of headache days in the month post-treatment was.9 (9.7,.)* Mean difference in number of headache days (pre-treatment minus post-treatment) was. (8.,.)* Findings were clinically and statistically significant Number of Headache days 0 *Numbers in parenthesis are the 9% Confidence Interval Headaches Pre Veterans Headaches Post * patients did not have a reduction in number of headache days, but did have a reduction in severity of headaches Limitations/Needs Results are promising in treating CM and Occipital neuralgia with Botox and Occipital Blocks Limitations: Inability to have treatment and control group small sample size (N=30) self report for only one month pre and post treatment Needs: Long term study Larger cohort controlled for confounders Additional studies for CM/Occipital neuralgia treatment in the veteran population Final Thoughts Post 9/ combat veterans, with a history of TBI or neck trauma/whiplash with findings of CM and occipital neuralgia, who have not had satisfactory relief of their CM with conventional medical treatment, may have a reduction in the number of days of headache after treatment with occipital blocks and Botox In other words: it may reduce the headache burden and improve quality of life
5 8//8 Karen Williams Central Texas Veterans Health Care System 90 Veterans Memorial Drive Temple, TX 70 Altalib, H. H., Fenton, B. T., Sico, J., Goulet, J. L., Bathulapalli, H., Mohammad, A.,... Haskell, S. (0). Increase in migraine diagnoses and guideline-concordant treatment in veterans, Cephalalgia: An International Journal of Headache. Advance on Line Publication. doi: Blumenfeld, A, Silberstein SD, Dodick DW, Aurora SK, Turkel CC, Binder WJ. Method of injection of OnabotulinumtoxinA for chronic migraine: A safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program. Headache: The Journal of Head and Face Pain. 0;0(9): doi:./j x Couch, J. R., & Stewart, K. E. (0). Headache prevalence at years after deployment-related traumatic brain injury in veterans of Iraq and Afghanistan wars and comparison to controls: A matched case-controlled study. Headache: The Journal of Head and Face Pain, (), 0-. doi:./head.837 Cuadrado, M. L., Aledo-Serrano, A., Navarro, P., Lopez-Ruiz, P., Fernandez-de-Las-Penas, C., Gonzalez-Suarez, I.,... Fernandez-Perez, C. (0). Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial. Cephalalgia : An International Journal of Headache, doi:03339 Ducic, I., Sinkin, J. C., & Crutchfield, K. E. (0). Interdisciplinary treatment of post-concussion and post-traumatic headaches. Microsurgery, 3(8), doi:.0/micr.03 DoD Worldwide Number for TBI. (0, Aug). Retrieved from mil/files/tbinumbers/dod-tbi-worldwide-totals_000-0_feb-7-07_v.0_ pdf Finkel, A. G., Yerry, J. A., Klaric, J. S., Ivins, B. J., Scher, A., & Choi, Y. S. (0). Headache in military service members with a history of mild traumatic brain injury: A cohort study of diagnosis and classification. Cephalalgia: An International Journal of Headache. Advance online publication. doi:03338 Gul, H. L., Ozon, A. O., Karadas, O., Koc, G., & Inan, L. E. (0). The efficacy of greater occipital nerve blockade in chronic migraine: A placebo-controlled study. Acta Neurologica Scandinavica, n/a. doi:./ane.7 Headache Classification Committee of the International Headache Society, (IHS). (03). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia : An International Journal of Headache, 33(9), doi:.77/ Management of Concussion-mild Traumatic Brain Injury (mtbi). Retrieved from Healthquality.va.gov/guidelines/Rehab/mtbi Munakata, J., Hazard, E., Serrano, D., Klingman, D., Rupnow, M. F. T., Tierce, J.,... Lipton, R. B. (009). Economic Burden of Transformed Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) study. Headache: The Journal of Head and Face Pain, 9, doi:./j x National Center for Veterans Analysis and Statistics. (0, May). Profile of Post - 9/ Veterans: 0. Retrieved from Patil, V. K., St. Andre, J. R., Crisan, E., Smith, B. M., Evans, C. T., Steiner, M. L., & Pape, T. L. (0). Prevalence and treatment of headaches in veterans with mild traumatic brain injury. Headache: The Journal of Head & Face Pain,, -. doi:./j x Theeler, B. J., & Erickson, J. C. (009). Mild head trauma and chronic headaches in returning US soldiers. Headache: The Journal of Head and Face Pain, 9, 9-3. doi:./j x Theeler, B. J., Flynn, F. G., & Erickson, J. C. (0). Chronic daily headache in U.S. soldiers after concussion. Headache: The Journal of Head and Face Pain,, doi:./j x Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M.,... Atkinson, C. (03). Years Lived with Disability (YLDs) for Sequelae of 89 Diseases and Injuries 990-0: A Systematic Analysis for the Global Burden of Disease Study 0. Lancet, 380 North American Edition (989), 3-9. doi:./s00-73()79-
6 8//8 Yerry, J. A., Kuehn, D., & Finkel, A. G. (0). Onabotulinum toxin A for the treatment of headache in service members with a history of mild traumatic brain injury: A cohort study. Headache: The Journal of Head & Face Pain,, doi:./head.9 Zaremski, J. L., Herman, D. C., Clugston, J. R., Hurley, R. W., & Ahn, A. H. (0). Occipital neuralgia as a sequela of sports concussion: A case series and review of the literature. Current Sports Medicine Reports (American College of Sports Medicine), (), -9. doi:.9/jsr
Mild Head Trauma and Chronic Headaches in Returning US Soldiers. Brett J. Theeler, MD; Jay C. Erickson, MD, PhD
Headache 2009 the Authors Journal compilation 2009 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2009.01345.x Published by Wiley Periodicals, Inc. Research Submission Mild Head Trauma
More informationDavid W. Dodick M.D. Professor Director of Headache Medicine Department of Neurology Mayo Clinic Phoenix Arizona USA
Headache Masters School 2013 in Asia Sunday March 24, 2013 Procedural Medicine Workshop Onabotulinumtoxin A: Evidence, Injection Technique, and Mechanism of Action David W. Dodick M.D. Professor Director
More informationDoes analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse
DOI 10.1186/s40064-015-1386-8 RESEARCH Open Access Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse Fayyaz Ahmed *, Hassan
More informationNeurological Findings & Symptoms Associated with Acute Combat related Concussion: Disclosures. Impact of Migraine and Other Co morbidities
Neurological Findings & Symptoms Associated with Acute Combat related Concussion: Impact of Migraine and Other Co morbidities COL Beverly R. Scott Madigan Healthcare System Disclosures The views expressed
More information6/2/2017. Objectives. Statement of Problem: Migraine Headaches Are Common. Chronic Headache In Pediatrics, Botox and Beyond
Chronic Headache In Pediatrics, Botox and Beyond Ken Mack MD PhD Mayo Clinic 2015 MFMER slide-1 Objectives Understand pediatric chronic headache presentations Review evidence for the treatment of chronic
More informationDisclosures. Objectives 11/10/2017. Research funding: Consultant and advisory: NIDILRR Wadsworth Foundation. Allergan Amgen Lilly Teva
AHS Scottsdale Headache Symposium 2017 Long Term Management of Posttraumatic Headache Sylvia Lucas MD, PhD, FAHS Clinical Professor of Neurology & Neurological Surgery Adjunct, Rehabilitation Medicine
More informationMark W. Green, MD, FAAN
Mark W. Green, MD, FAAN Professor of Neurology, Anesthesiology, and Rehabilitation Medicine Director of Headache and Pain Medicine Icahn School of Medicine at Mt Sinai New York Pain-sensitive structures
More information6/20/2018 PROCEDURAL TREATMENTS FOR HEADACHE. Case study: Emily. Diary
Headache severity (Scale 0 10) Topiramate started on July 20, D/C July 29 Amitriptyline initiated, D/C on Sep 23 PROCEDURAL TREATMENTS FOR HEADACHE Andrew M. Blumenfeld Director of the Headache Center
More informationDefining the Differences Between Episodic Migraine and Chronic Migraine
Curr Pain Headache Rep (2012) 16:86 92 DOI 10.1007/s11916-011-0233-z CHRONIC DAILY HEADACHE (SJ WANG, SECTION EDITOR) Defining the Differences Between Episodic Migraine and Chronic Migraine Zaza Katsarava
More informationNeuropsychology of TBI & PTSD
Neuropsychology of TBI & PTSD George S. Serna, Ph.D. Louis Stokes VA Medical Center TBI: The Signature Injury of the Iraq/Afghanistan War Veteran? 19% - 30% of OEF/OIF veterans reported some level of TBI
More informationJournal of Anesthesia & Pain Medicine
Case Report To spasm, or Not to Spasm, That is the Question Journal of Anesthesia & Pain Medicine John C McDonald BA 1 and Terence K Gray DO 1,2* 1 Mercy Pain Center, Mercy Hospital, Portland, Maine, USA
More informationOnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm
Pedraza et al. SpringerPlus (2015) 4:176 DOI 10.1186/s40064-015-0957-z a SpringerOpen Journal RESEARCH Open Access OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with
More informationRISK FACTORS AND PROGNOSIS OF CHRONIC MIGRAINE
RISK FACTORS AND PROGNOSIS OF CHRONIC MIGRAINE Gretchen E. Tietjen, MD University of Toledo Toledo, Ohio Learning objectives At the conclusion of this presentation, participants should be able to: 1. Understand
More informationPost Traumatic Headache
Post Traumatic Headache Alan G Finkel MD FAAN FAHS Contractor supporting the Defense and Veteran Brain Injury Center (DVBIC) Womack Army Medical Center, Ft Bragg, NC 20SEP2013 Disclosures With regards
More informationCognitive-linguistic correlates in Athletes and Soldiers
Cognitive-linguistic correlates in Athletes and Soldiers Bess Sirmon Fjordbak, PhD, CCC-SLP Anthony P. Salvatore, PhD, CCC-SLP, BC-ANCDS Edina R. Bene, PhD University of Texas at El Paso 1 Neurometabolic
More informationBotox (Ona Botulinum Toxin Type A) For Treatment Of Chronic Daily Migraine Headaches (CDMH) In Veterans With Traumatic Brain Injury
Botox (Ona Botulinum Toxin Type A) For Treatment Of Chronic Daily Migraine Headaches (CDMH) In Veterans With Traumatic Brain Injury DR. SALLY ZACHARIAH M.D., F.A.A.N. NEUROLOGIST/STROKE SPECIALIST BAY
More informationWhat is new in the migraine world! Modar Khalil Consultant neurologist Hull Royal Infirmary
What is new in the migraine world! Modar Khalil Consultant neurologist Hull Royal Infirmary Overview Understanding the burden Commonly used terms Acute therapy What we currently have What we are going
More informationExpert Opinion. OnabotulinumtoxinA for Chronic Migrainehead_2071 CLINICAL HISTORY. Andrew Blumenfeld, MD; Randolph W. Evans, MD
142..148 Headache 2011 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2011.02081.x Published by Wiley Periodicals, Inc. Expert Opinion OnabotulinumtoxinA for Chronic Migrainehead_2071
More informationIs OnabotulinumtoxinA Good for Other Head and Face Pain? Disclosures BoNT/A for non- CM Botulinum neurotoxin (BoNT) in clinical use for headache >20
1 2 3 4 5 6 Is OnabotulinumtoxinA Good for Other Head and Face Pain? Disclosures BoNT/A for non- CM Botulinum neurotoxin (BoNT) in clinical use for headache >20 years Efficacy of BoNT type A (onabotulinumtoxina,
More informationWhat is the Effectiveness of OnabotulinumtoxinA (Botox ) in Reducing the Number of Chronic Migraines (CM) in Patients Years Old?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2013 What is the Effectiveness of OnabotulinumtoxinA
More information2 nd Resubmission. 13 January 2017
2 nd Resubmission botulinum toxin A, 50 Allergan units, 100 Allergan units, 200 Allergan units, powder for solution for injection (Botox ) SMC No. (692/11) Allergan Limited 13 January 2017 The Scottish
More informationCombat-Related Traumatic Brain Injury And PTSD: A Resource And Recovery Guide (Military Life) By Don Philpott
Combat-Related Traumatic Brain Injury And PTSD: A Resource And Recovery Guide (Military Life) By Don Philpott If searching for the book Combat-Related Traumatic Brain Injury and PTSD: A Resource and Recovery
More informationAn increasing number of studies in recent years have
Aches and Trauma: Understanding Post- Traumatic Headache, Part 2: Management and Treatment Despite limited options for the treatment of post-traumatic headache, some evidence suggests potential for select
More informationA prospective study of prevalence and characterization of headache following mild traumatic brain injury
Original Article A prospective study of prevalence and characterization of headache following mild traumatic brain injury Cephalalgia 2014, Vol 34(2) 93 102! International Headache Society 2013 Reprints
More informationOnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study The Harvard community has made this article openly available. Please share how this access benefits you. Your story
More informationCalcitonin Gene-Related Peptide (CGRP) Inhibitors as Preventive Treatments for Patients with Episodic or Chronic Migraine: Effectiveness and Value
Calcitonin Gene-Related Peptide (CGRP) Inhibitors as Preventive Treatments for Patients with Episodic or Chronic Migraine: Effectiveness and Value Background Draft Background and Scope December 4, 2017
More information3/13/2012. Blast out pressurization wave travels at high velocity and is affected by surrounding environment
Sarah Wagers, MD, Poly Clinic Medical Director Vickie Zaborowski, Polytrauma Coordinator Robley Rex VA Medical Center, Louisville, Kentucky 6 th Annual Northern Kentucky TBI Conference March 23, 2012 www.bridgesnky.org
More informationVA/DoD Clinical Practice Guideline for the Management of Concussion/mTBI
VA/DoD Clinical Practice Guideline for the Management of Concussion/mTBI Chief, Evidence-Based Practice US Army Medical Command Clinical Program Specialist Office of Performance and Quality Improvement
More informationMedical Policy. Description/Scope. Position Statement. Rationale
Subject: Document#: Current Effective Date: 06/28/2017 Status: Reviewed Last Review Date: 05/04/2017 Description/Scope This document addresses occipital nerve stimulation (ONS), which involves delivering
More informationCharacteristics of posttraumatic headache following mild traumatic brain injury in military personnel in Iran
Environ Health Prev Med (2014) 19:422 428 DOI 10.1007/s12199-014-0409-3 REGULAR ARTICLE Characteristics of posttraumatic headache following mild traumatic brain injury in military personnel in Iran Saeid
More informationCurrent Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN
Current Migraine Treatment Therapy Daniel Kassicieh, DO, FAAN Migraine a Disease Process Migraines are a chronic disease process similar to many other chronic medical conditions Migraine has a low mortality
More informationAffiliation: 1- Departments of Anesthesiology/ Pain Management and Neurology, UCSF School of Medicine 2- Thrive Clinic, LLC, Santa Rosa, CA
Author Information Prasad Shirvalkar MD, PhD 1 Jason E. Pope MD 2 Affiliation: 1- Departments of Anesthesiology/ Pain Management and Neurology, UCSF School of Medicine 2- Thrive Clinic, LLC, Santa Rosa,
More informationA Multi-Center Double-Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic Migrainehead_
Headache 2010 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2010.01796.x Published by Wiley Periodicals, Inc. Research Submission A Multi-Center Double-Blind Pilot Comparison of OnabotulinumtoxinA
More informationHeadache evaluation and management after concussion. Assistant Professor
Headache evaluation and management after concussion Juliette Preston, M.D. Assistant Professor OHSU Headache Center OVERVIEW Introduction Definition Acute post-traumatic headache Red flags Persistent post-traumatic
More informationThe course of headache in patients with moderate-to-severe headache due to mild traumatic brain injury: a retrospective cross-sectional study
Hong et al. The Journal of Headache and Pain (2017) 18:48 DOI 10.1186/s10194-017-0755-9 The Journal of Headache and Pain RESEARCH ARTICLE The course of headache in patients with moderate-to-severe headache
More informationEmotional Symptoms in Athletes With PCS. David Westerdahl, MD FAAFP Cleveland Clinic Florida 6/24/2012
Emotional Symptoms in Athletes With PCS David Westerdahl, MD FAAFP Cleveland Clinic Florida 6/24/2012 Objectives Discuss Post-Concussion symptoms and functional problems Identify pre-injury factors that
More information10/19/12. Post-Traumatic Headache. Lawrence J. Horn, MD Disclosures. Speakers Bureau: Allergan, Inc.
10/19/12 Post-Traumatic Headache Professor and Interim Chair, Department of PM&R Wayne State University School of Medicine Detroit, MI Medical Director Neuroscience Rehabilitation Institute of Michigan
More informationPreventive Effect of Greater Occipital Nerve Block on Severity and Frequency of Migraine Headache
Global Journal of Health Science; Vol. 6, No. 6; 2014 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Preventive Effect of Greater Occipital Nerve Block on Severity
More informationFor surveillance purposes, a case of adjustment disorder is defined as:
1 MH 12 ADJUSTMENT DISORDERS Does Not Include Acute Stress Reaction or Post Traumatic Stress Disorder (PTSD); For PTSD, See Post-Traumatic Stress Disorder Case Definition. Background This case definition
More informationGet ahead of the ACHE: Monoclonal Antibodies in Migraine Prevention
Get ahead of the ACHE: Monoclonal Antibodies in Migraine Prevention Amanda Janisch, PharmD PGY2 Ambulatory Care Pharmacy Resident MCHS SWMN, Mankato, MN 2018 MFMER slide-1 Disclosures No financial interest
More informationSafety and efficacy of cervical 10 khz spinal cord stimulation in chronic refractory primary headaches: a retrospective case series
Lambru et al. The Journal of Headache and Pain (2016) 17:66 DOI 10.1186/s10194-016-0657-2 The Journal of Headache and Pain SHORT REPORT Open Access Safety and efficacy of cervical 10 khz spinal cord stimulation
More informationMedical and Rehabilitation Innovations Hyperbaric Oxygen Therapy for Traumatic Brain Injury
Medical and Rehabilitation Innovations Hyperbaric Oxygen Therapy for Traumatic Brain Injury BACKGROUND Traumatic Brain Injuries (TBI) have become a national interest over the recent years due to a growing
More informationPeripheral Subcutaneous Field Stimulation. Description
Subject: Peripheral Subcutaneous Field Stimulation Page: 1 of 6 Last Review Status/Date: June 2016 Peripheral Subcutaneous Field Stimulation Description Peripheral subcutaneous field stimulation (PSFS,
More informationPreventive treatment of migraine. Rebecca Burch, MD Brigham and Women s Faulkner Hospital Harvard Medical School Boston, MA
Preventive treatment of migraine Rebecca Burch, MD Brigham and Women s Faulkner Hospital Harvard Medical School Boston, MA No disclosures Disclosures Many preventive treatments for migraine are not FDA-approved
More informationHandbook of. Polytrauma Care and. Rehabilitation. David X. Cifu Henry L. Lew
Handbook of Polytrauma Care and Rehabilitation David X. Cifu Henry L. Lew Handbook of Polytrauma Care and Rehabilitation Handbook of Polytrauma Care and Rehabilitation David X. Cifu, MD Chairman and Herman
More informationHeads Up: Concussion Management. Laurel Short, MSN, FNP-c
Heads Up: Concussion Management Laurel Short, MSN, FNP-c Diclosure I have no current affiliation or financial interest with any grantor or commercial interests that may have direct interest in the subject
More informationpsychological trauma is an experience of a threat to life, body, or sanity so severe as to overwhelm the ordinary process of emotional integration.
Virtual Reality in the Treatment of Combat-Related PTSD with Warfighters Sarah D. Miyahira, Ph.D. Director of Intramural Research Co-Director, VR Behavioral Health Program & Laboratory Department of Veterans
More informationPeripheral Subcutaneous Field Stimulation
Peripheral Subcutaneous Field Stimulation Policy Number: 7.01.139 Last Review: 3/2018 Origination: 7/2013 Next Review: 9/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide
More informationTears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE
Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE IHS Classification 1989 (updated 2004) Primary Headaches 4 categories Migraine Tension-type Cluster and other trigeminal
More informationTraumatic Brain Injury. By Laura Gomez, LCSW
Traumatic Brain Injury By Laura Gomez, LCSW Objectives Briefly describe TBI, and its incidence, severity, and treatments Describe the VHA system of specialized TBI care for active duty and veterans Describe
More informationTRAUMATIC BRAIN INJURY
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences TRAUMATIC BRAIN INJURY GARY STOBBE, MD UNIVERSITY OF WASHINGTON GENERAL DISCLOSURES The University of Washington
More informationMeasure Components Numerator Statement
MEASURE #5: OVERUSE OF OPIOID CONTAINING MEDICATIONS FOR PRIMARY HEADACHE DISORDERS Headache For Quality Improvement Only. Not to be used for Public Reporting or Accountability Measure Description Percentage
More informationDr Peter Gendall. Mr Steve August. Professor Nik Bogduk. Musculoskeletal Radiologist Hamilton. Physiotherapist Dunedin
Professor Nik Bogduk Professor Pain Medicine University of Newcastle Mr Steve August Physiotherapist Dunedin Dr Peter Gendall Musculoskeletal Radiologist Hamilton 8:30-10:30 WS #5: Musculoskeletal Medicine
More informationBOTULINUM TOXIN POLICY TO INCLUDE:
BOTULINUM TOXIN POLICY TO INCLUDE: Blepharospasm in adults, Hemi facial spasm in adults, spasmodic torticollis (cervical dystonia), focal spasticity treatment of dynamic equinus foot deformity, focal spasticity
More informationOCCIPITAL NEURALGIA AND HEADACHE TREATMENT
UnitedHealthcare Commercial Medical Policy OCCIPITAL NEURALGIA AND HEADACHE TREATMENT Policy Number: NEU027 Effective Date: April 1, 2019 Table of Contents Page COVERAGE RATIONALE... 1 DEFINITIONS... 1
More informationBOSTON ASSESSMENT OF TBI-LIFETIME BAT-L VA BOSTON HEALTHCARE SYSTEM
BAT-L VA BOSTON HEALTHCARE SYSTEM THIS RESEARCH WAS SUPPORTED BY THE TRANSLATIONAL RESEARCH CENTER FOR TBI AND STRESS DISORDERS (TRACTS) A VA REHABILITATION RESEARCH AND DEVELOPMENT NATIONAL NETWORK CENTER
More informationOxycodone for concussion
Oxycodone for concussion Search A list of common prescription medications & drugs that can cause memory loss symptoms: benzodiazepines, antihistamines, anticholinergics, sleep aids,. 27-9-2011 The age
More informationAdjunct Lecturer. National Yang-Ming University, Taiwan. Taipei Veterans General Hospital, Taiwan
Kuan-Po Peng MD Adjunct Lecturer National Yang-Ming University, Taiwan Taipei Veterans General Hospital, Taiwan Nothing to declare Disclosure Experience from the Taiwan National Health Insurance Research
More informationMedical Policy Manual. Topic: Peripheral Subcutaneous Field Stimulation Date of Origin: April Section: Surgery Last Reviewed Date: April 2014
Medical Policy Manual Topic: Peripheral Subcutaneous Field Stimulation Date of Origin: April 2013 Section: Surgery Last Reviewed Date: April 2014 Policy No: 188 Effective Date: July 1, 2014 IMPORTANT REMINDER
More informationThe Advancement of Traumatic Brain Injury (TBI) Care During Modern Warfare
The Advancement of Traumatic Brain Injury (TBI) Care During Modern Warfare Helen C. Coronel, MSN BC Office of Clinical Initiatives Defense and Veterans Brain Injury Center Washington, DC 1 Disclaimer The
More information10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD
Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD } Depomed Consultant 2014 to present } Avanir Consultant 2014 to present } Amgen
More informationUNDERSTANDING CHRONIC PAIN in CHILDREN. The Problem of Children s Pain 4/14/2009 OVERVIEW
UNDERSTANDING CHRONIC PAIN in CHILDREN LONNIE ZELTZER MD DIRECTOR UCLA PEDIATRIC PAIN PROGRAM PROFESSOR OF PEDIATRICS, ANESTHESIOLOGY, PSYCHIATRY AND BIOBEHAVIORAL SCIENCES OVERVIEW THE PROBLEM OF PAIN
More information10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY
BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES JENNIFER SHIN, PHARMD PGY2 AMBULATORY CARE PHARMACY RESIDENT COMMUNITYCARE HEALTH CENTERS PHARMACOTHERAPY ROUNDS OCTOBER 20, 2017
More informationPTSD and Other Invisible Wounds affecting our Service Members and Veterans. Alan Peterson, PhD, ABPP
PTSD and Other Invisible Wounds affecting our Service Members and Veterans Alan Peterson, PhD, ABPP 1 Alan Peterson, PhD, ABPP Retired USAF Lt Col Clinical Health Psychologist Former Chair, Department
More informationEffective Use of Headache Calendars. Brian D. Loftus, M.D. Bellaire Neurology
Effective Use of Headache Calendars Brian D. Loftus, M.D. Bellaire Neurology Conflicts of Interest I am a co-founder of BetterQOL, Inc which has developed an electronic diary iheadache App, iheadache Online,
More informationPrevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.
Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D. Objectives Present patient case Review epidemiology/pathophysiology
More informationPeripheral Subcutaneous Field Stimulation
Peripheral Subcutaneous Field Stimulation Policy Number: 7.01.139 Last Review: 9/2018 Origination: 7/2013 Next Review: 3/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide
More informationDBQ Initial Evaluation of Residuals of Traumatic Brain Injury (I-TBI) Disability
DBQ Initial Evaluation of Residuals of Traumatic Brain Injury (I-TBI) Disability Name of patient/veteran: SSN: SECTION I 1. Diagnosis Does the Veteran now have or has he/she ever had a traumatic brain
More informationVA/DoD Clinical Practice Guidelines for Management of Concussion/mTBI
VA/DoD Clinical Practice Guidelines for Management of Concussion/mTBI Ernest Degenhardt Chief, Evidence-Based Practice USA Medical Command Quality Management Division Office of Evidence-Based Practice
More informationPeripheral Subcutaneous Field Stimulation
Peripheral Subcutaneous Field Stimulation Policy Number: 7.01.139 Last Review: 9/2014 Origination: 7/2013 Next Review: 1/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide
More informationA single-center retrospective study of onabotulinumtoxina for treatment of 245 chronic migraine patients: survey results of a realworld
https://doi.org/10.1007/s13760-018-0978-9 ORIGINAL ARTICLE A single-center retrospective study of onabotulinumtoxina for treatment of 245 chronic migraine patients: survey results of a realworld experience
More informationProfessor Stacey-Rae Simcox Stetson University College of Law Director, Veterans Advocacy Clinic
Professor Stacey-Rae Simcox Stetson University College of Law Director, Veterans Advocacy Clinic To assist veterans with filing claims for VA disability compensation/pension benefits Serve the veterans
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
CGRP Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: CGRP (calcitonin gene-related peptide) Prime Therapeutics will review Prior Authorization requests
More informationOnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience
731521TAN0010.1177/1756285617731521Therapeutic Advances in Neurological DisordersC-C Chiang and AJ Starling research-article2017 Therapeutic Advances in Neurological Disorders Review OnabotulinumtoxinA
More informationNational Institute for Health and Clinical Excellence. Single Technology Appraisal (STA)
National Institute for Health and Clinical Excellence Comment 1: the draft remit Single Technology Appraisal (STA) Botulinum toxin type A for the prophylaxis of headaches in adults with chronic migraine
More informationDisclosures. Objectives 6/2/2017
Classification: Migraine and Trigeminal Autonomic Cephalalgias Lauren Doyle Strauss, DO, FAHS Assistant Professor, Child Neurology Assistant Director, Child Neurology Residency @StraussHeadache No disclosures
More information1/25/2018 ARE CGRP ANTAGONISTS ANY BETTER THAN CURRENT EVIDENCE BASED TREATMENTS? Disclosures: Objectives: Headache Division
ARE CGRP ANTAGONISTS ANY BETTER THAN CURRENT EVIDENCE BASED TREATMENTS? Lawrence C Newman, MD, FAHS, FAAN Clinical Professor of Neurology Disclosures: Advisory Board: Alder, Allergan, Amgen, Lilly, Supernus,
More informationPreventive Effect of Greater Occipital Nerve Block on Severity and Frequency of Migraine Headache
Proceeding S.Z.P.G.M.I. Vol: 31(2): pp. 75-79, 2017. Preventive effect of Greater Occipital Nerve Block on Severity and Frequency of Migraine Headache Dr. Syed Mehmood Ali, Dr. Mudassar Aslam, Dr. Dawood
More informationPeripheral Subcutaneous Field Stimulation
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationBrain Injury and Epilepsy
Slide 1 Brain Injury and Epilepsy Presented by: Paula St. John, MA Education and Community Outreach Manager Minnesota Brain injury Alliance www.braininjurymn.org l 612-378-2742 800-669-6442 Slide 2 Objectives:
More informationMedication overuse headache is a severe chronic pain condition that is preventable and treatable. An International Experience
Medication overuse headache is a severe chronic pain condition that is preventable and treatable An International Experience C. Tassorelli Chair of Neurolgy, Department of Brain and Behavioral Sciences,
More informationA two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience
Negro et al. The Journal of Headache and Pain (2016) 17:1 DOI 10.1186/s10194-016-0591-3 RESEARCH ARTICLE A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache:
More informationปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา
ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา 1 CONTENT 1 2 3 Chronic Daily Headache Medical Overused Headache Management Headaches are one of the most common symptoms List
More informationClinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.
OVERVIEW Refractory headaches and update on novel treatment Definition of refractory headache Treatment approach Medications Neuromodulation In the pipeline Juliette Preston, MD OHSU Headache Center Refractory
More informationArmy troops suffering from traumatic brain injury
Army troops suffering from traumatic brain injury Since October 2001, more than two million American troops have deployed to fight the Global War on Terror being fought in Iraq and Afghanistan. The War
More information(U) USSOCOM. (U) Magnetic qeeg guided Resonance Therapy (MeRT)
United States Special Operations Command (U) USSOCOM MeRT Clinical Trial for Treatment of TBI COL Mark Baggett, Ph.D., US Army USSOCOM Command Psychologist Date: 14 Feb 2018 1 (U) Magnetic qeeg guided
More informationOCCIPITAL NEURALGIA AND HEADACHE TREATMENT
Oxford UnitedHealthcare Oxford Clinical Policy OCCIPITAL NEURALGIA AND HEADACHE TREATMENT Policy Number: PAIN 018.24 T2 Effective Date: November 1, 2018 Instructions for Use Table of Contents Page CONDITIONS
More informationAleksandra Radojičić. Headache Center, Neurology Clinic, Clinical Center of Serbia
European Headache School Belgrade 2012 MEDICATION OVERUSE HEADACHE Aleksandra Radojičić Headache Center, Neurology Clinic, Clinical Center of Serbia Historical data First cases were described in XVII century
More informationPain among returning service members from OEF/OIF
Pain among returning service members from OEF/OIF Robert D. Kerns, Ph.D. Chief, Psychology Service, VA Connecticut National Program Director for Pain Management, VACO Professor of Psychiatry, Neurology
More information8-May-2018 ICER OPEN COMMENT PERIOD ON CGRP INHIBITORS FOR MIGRAINE. Submitted electronically to:
8-May-2018 ICER OPEN COMMENT PERIOD ON CGRP INHIBITORS FOR MIGRAINE Submitted electronically to: publiccomments@icer-review.org Steven D. Pearson, MD, President Institute for Clinical and Economic Review
More informationAalborg Universitet. Botulinum neurotoxin A for chronic migraine headaches Cairns, Brian Edwin; Gazerani, Parisa. Published in: Pain Management
Aalborg Universitet Botulinum neurotoxin A for chronic migraine headaches Cairns, Brian Edwin; Gazerani, Parisa Published in: Pain Management DOI (link to publication from Publisher): 10.2217/PMT.14.30
More informationOccipital Nerve Blockage in Cervicogenic Headache: A case Report and Brief Review of Literature
Occipital Nerve Blockage in Cervicogenic Headache: A case Report and Brief Review of Literature Tuba Tulay Koca Department of Physical Medicine and Rehabilitation, State Hospital, Malatya, Turkey Abstract
More informationChronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary
Chronic Migraine in Primary Care December 11 th, 2017 Werner J. Becker University of Calgary Disclosures Faculty: Werner J. Becker Relationships with commercial interests: Grants/Research Support: Clinical
More informationClinical Trials. Hans-Christoph Diener Senior Professor of Clinical Neuroscienes Medical Faculty University Duisburg-Essen Germany
Clinical Trials Hans-Christoph Diener Senior Professor of Clinical Neuroscienes Medical Faculty University Duisburg-Essen Germany Conflict of Interest Statement German Research Council German Ministry
More informationTranscutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine Cluster
More informationThe frequency with which migraine attacks
STRATEGIES TO PREVENT MIGRAINE * Sheena K. Aurora, MD ABSTRACT Patients who suffer from daily or near-daily headaches may experience significant disability and interference in all aspects of their professional
More informationIT S ALL IN YOUR HEAD!
IT S ALL IN YOUR HEAD! CARING FOR CONCUSSIONS IN YOUR COMMUNITY Stephen K Stacey, DO CPT, MC, USA OUTLINE Definition Epidemiology Diagnosis Evaluation Recovery Sequelae Prevention Resources for providers
More informationConcussion. James R. Borchers, MD, MPH
Concussion James R. Borchers, MD, MPH Associate Clinical Professor Director, Division of Sports Medicine, Department of Family Medicine Head Team Physician, Athletic Department Jameson Crane Sports Medicine
More informationEpidemiology of concussion: Risk factors, sequelae and implications for tactical athletes
Epidemiology of concussion: Risk factors, sequelae and implications for tactical athletes Dennis E. Scofield Joseph R. Kardouni Disclaimers The opinions or assertions contained herein are the private views
More informationOH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES
1 JUSTIN A. OSSMAN, MD CHATTANOOGA FAMILY MEDICINE UPDATE OH, MY ACHING HEAD! MANAGING HEADACHE IN THE OUTPATIENT SETTING 2 I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE OBJECTIVES International
More information